Advertisement

Table of Contents

November 01, 1995; Volume 48,Issue 5

You have access
Mutation of Asp100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction.
A Jagerschmidt, N Guillaume, N Goudreau, B Maigret and B P Roques

Molecular Pharmacology November 1995, 48 (5) 783-789;
You have access
Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate.
D J Waxman, P A Ram, N A Pampori and B H Shapiro

Molecular Pharmacology November 1995, 48 (5) 790-797;
You have access
Hypophosphorylation of topoisomerase II in etoposide (VP-16)-resistant human leukemia K562 cells associated with reduced levels of beta II protein kinase C.
M K Ritke, N R Murray, W P Allan, A P Fields and J C Yalowich

Molecular Pharmacology November 1995, 48 (5) 798-805;
You have access
Species differences in A1 adenosine receptor/G protein coupling: identification of a membrane protein that stabilizes the association of the receptor/G protein complex.
C Nanoff, T Mitterauer, F Roka, M Hohenegger and M Freissmuth

Molecular Pharmacology November 1995, 48 (5) 806-817;
You have access
Agonist-stimulated phosphorylation of the carboxyl-terminal tail of the secretin receptor.
F Ozcelebi, M H Holtmann, R U Rentsch, R Rao and L J Miller

Molecular Pharmacology November 1995, 48 (5) 818-824;
You have access
Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes.
C García-Ruiz, A Colell, A Morales, N Kaplowitz and J C Fernández-Checa

Molecular Pharmacology November 1995, 48 (5) 825-834;
You have access
Subunit composition determines picrotoxin and bicuculline sensitivity of Drosophila gamma-aminobutyric acid receptors.
H G Zhang, H J Lee, T Rocheleau, R H ffrench-Constant and M B Jackson

Molecular Pharmacology November 1995, 48 (5) 835-840;
You have access
Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
T Priestley, P Laughton, J Myers, B Le Bourdellés, J Kerby and P J Whiting

Molecular Pharmacology November 1995, 48 (5) 841-848;
You have access
Differential coupling of glucagon and beta-adrenergic receptors with the small and large forms of the stimulatory G protein.
T Yagami

Molecular Pharmacology November 1995, 48 (5) 849-854;
You have access
Glutamine transaminase K is not a major cysteine S-conjugate beta-lyase of rat kidney mitochondria: evidence that a high-molecular weight enzyme fulfills this role.
D G Abraham, R J Thomas and A J Cooper

Molecular Pharmacology November 1995, 48 (5) 855-860;
You have access
Chronic ethanol consumption differentially alters the expression of gamma-aminobutyric acidA receptor subunit mRNAs in rat cerebral cortex: competitive, quantitative reverse transcriptase-polymerase chain reaction analysis.
L L Devaud, F D Smith, D R Grayson and A L Morrow

Molecular Pharmacology November 1995, 48 (5) 861-868;
You have access
Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions.
M Kotani, I Tanaka, Y Ogawa, T Usui, K Mori, A Ichikawa, S Narumiya, T Yoshimi and K Nakao

Molecular Pharmacology November 1995, 48 (5) 869-879;
You have access
Regulation of delta FosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments.
J Chen, H E Nye, M B Kelz, N Hiroi, Y Nakabeppu, B T Hope and E J Nestler

Molecular Pharmacology November 1995, 48 (5) 880-889;
You have access
Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades.
D A Jones, C W Benjamin and D A Linseman

Molecular Pharmacology November 1995, 48 (5) 890-896;
You have access
In vitro transcription of DNA containing 2-chloro-2'-deoxyadenosine monophosphate.
P Hentosh and M Tibudan

Molecular Pharmacology November 1995, 48 (5) 897-904;
You have access
Inhibition of splicing of wild-type and mutated luciferase-adenovirus pre-mRNAs by antisense oligonucleotides.
D Hodges and S T Crooke

Molecular Pharmacology November 1995, 48 (5) 905-918;
You have access
Pharmacology of the inhibitory glycine receptor: agonist and antagonist actions of amino acids and piperidine carboxylic acid compounds.
V Schmieden and H Betz

Molecular Pharmacology November 1995, 48 (5) 919-927;
You have access
Inhibition of succinate:ubiquinone reductase and decrease of ubiquinol in nephrotoxic cysteine S-conjugate-induced oxidative cell injury.
B van de Water, J P Zoeteweij, H J de Bont and J F Nagelkerke

Molecular Pharmacology November 1995, 48 (5) 928-937;
You have access
Zinc ions antagonize the inhibitory effect of aurothiomalate on glucocorticoid receptor function at physiological concentrations.
H Tanaka, Y Makino, K Dahlman-Wright, J A Gustafsson, K Okamoto, I Makino and K ] Wright KD [corrected to Dahlman-Wright

Molecular Pharmacology November 1995, 48 (5) 938-945;
You have access
Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.
T H Johansen, A Chaudhary and T A Verdoorn

Molecular Pharmacology November 1995, 48 (5) 946-955;
You have access
Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells.
V A Boundy, M A Pacheco, W Guan and P B Molinoff

Molecular Pharmacology November 1995, 48 (5) 956-964;